Moleculin Biotech, Inc. is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center. Each of our projects represents a breakthrough discovery and a highly disruptive technology.

All SEC Filings

Date Form Description PDF XBRL Pages
08/11/17 S-3/A Registration statement for specified transactions by certain issuers
Documents
31
08/11/17 10-Q Quarterly report pursuant to Section 13 or 15(d) 35
08/01/17 UPLOAD SEC-generated letter 2
07/27/17 8-K Current report filing
Documents
8
07/26/17 4 Statement of changes in beneficial ownership of securities 1
07/26/17 4 Statement of changes in beneficial ownership of securities
Documents
3
07/26/17 4 Statement of changes in beneficial ownership of securities
Documents
3
07/26/17 3 Initial statement of beneficial ownership of securities
Documents
3
07/24/17 S-3 Registration statement for specified transactions by certain issuers 192
07/12/17 8-K Current report filing 2
RSS